The value of the innovative pharmaceutical industry – A report summary
This summary of a study by Deloitte combines a traditional economic impact analysis with targeted assessments of health system impacts […]
Connecting Canada to Better Health
Partnering to champion policies that drive the discovery, development and delivery of transformative medicines and vaccines.
BENEFITS OF INNOVATIVE MEDICINES
Real hope for patients and families
New medicines and vaccines save lives and help make our healthcare system more cost‑effective.
Transformation
Preventing or curing disease means extending lives, relieving suffering and improving people’s quality of life.
Safety
Promoting a robust regulatory protocol means ensuring safe and effective medicines for Canadians.
Sustainability
Supporting sustainable healthcare means we all spend more time enjoying life and being productive.
Industry impact In Canada
Better health outcomes
$25 billion
Total yearly economic impact
$3.5 billion
Invested annually in research and development
150,000
High-quality Canadian jobs
LATEST RESOURCES
Increasing access to innovative medicines
Written Submission for the Pre-Budget Consultations in Advance of the 2026-2027 New Brunswick Budget
Increasing access to innovative medicines
Written Submission for the Pre-Budget Consultations in Advance of the 2026 Newfoundland and Labrador Budget
Pre-budget submission 2026
Innovative Medicines Canada (IMC) is pleased to contribute to the Quebec government’s consultations on its 2026-27 budget. Availability of and […]
Increasing access to innovative medicines
Written Submission for the Pre-Budget Consultations in Advance of the 2026 Ontario Budget January 2026
Increasing access to innovative medicines
Written Submission for the Pre-Budget Consultations in Advance of the 2026 Alberta Budget
Increasing access to innovative medicines
Written Submission for the Pre-Budget Consultations in Advance of the 2026 Nova Scotia Budget
LATEST PRESS RELEASES
Press releases July 24, 2026
Federal task force report marks important step for Canada’s life sciences sector
Innovative Medicines Canada (IMC) acknowledges today’s publication of the Pharmaceutical and Life Sciences Sector Task Force report by the ministers of health and industry, featuring recommendations to improve patient access to life-saving medications. Turning these recommendations into urgent action will be critical given recent global drug policy shifts triggered by U.S. most-favoured nation pricing, which are already influencing where innovative medicines are launched.
Press releases July 23, 2026
IMC welcomes premiers’ call for sustainable healthcare funding
Innovative Medicines Canada (IMC) welcomes today’s call from Canada’s Premiers, issued at the Council of the Federation’s Summer Meeting in Charlottetown, for sustainable federal funding to help provinces and territories continue delivering timely, high-quality healthcare—including access to innovative medicines.
Press releases November 20, 2025
Innovative Medicines Canada and Roche Canada establish the Brigitte Nolet Scholarship for indigenous pathways into life sciences at York University
Innovative Medicines Canada (IMC) and Roche Canada are proud to announce the creation of the Brigitte Nolet Scholarship for Indigenous Pathways into Life Sciences. The $50,000 gift to York University’s Faculty of Health honours Brigitte Nolet’s exceptional leadership as Chair of IMC’s Board of Directors and her lasting contributions to Canada’s life sciences sector.
Press releases November 19, 2025
Innovative Medicines Canada announces Gaby Bourbara as chair of the board of directors
Innovative Medicines Canada (IMC) is pleased to announce the appointment of Gaby Bourbara, President of AstraZeneca Canada, as Chair of its Board of Directors.
Press releases October 07, 2025
IMC applauds Ontario government’s launch of new FAST program to accelerate patient access to innovative medicines
Innovative Medicines Canada (IMC) applauds the Government of Ontario for its pioneering announcement of the Funding Accelerated for Specific Treatments (FAST) Program, a new initiative designed to significantly reduce the time it takes for patients to access high-priority medicines.
Press releases September 19, 2025
IMC congratulates C.D. Howe Institute on timely report supporting practical pharmacare solutions
Innovative Medicines Canada (IMC) congratulates the C.D. Howe Institute on the publication of its timely and insightful report, Access and Affordability: Building Fiscally Responsible Pharmacare Systems. The report offers a well-reasoned, evidence-based contribution to one of Canada’s most important and complex health policy challenges.
Press releases September 19, 2025
Innovative Medicines Canada launches Medicine Matters Canada
Innovative Medicines Canada (IMC) is proud to announce the official launch of Medicine Matters Canada, a new national public advocacy platform dedicated to improving patient access to innovative medicines and strengthening Canada’s life sciences sector.
Press releases May 12, 2025
New Statistics Canada data reinforces life sciences as an economic engine
Innovative Pharmaceutical Industry Contributed $18.4 Billion to the Canadian Economy in 2022 Ottawa, May 12, 2024 – New data released […]
